Regeneron Pharmaceuticals (REGN.VI) Q2 2020 Earnings

5MayConfirmed
Q3 2019
Q4 2019
Q1 2020
Q2 2020
4.9
5.55
6.19
6.83

Details

Expected EPS
5.53764
Actual EPS
6.091404
Surprise EPS
0.55
Surprise Percent
+10%

Description

Regeneron Pharmaceuticals (REGN.VI) has reported earnings of 6.091404 per share for Q2 2020.

0 Comments

Share your thoughts